Need to revisit heart failure treatment guidelines for hyperkalaemia management during the use of mineralocorticoid receptor antagonists
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Need to revisit heart failure treatment guidelines for hyperkalaemia management during the use of mineralocorticoid receptor antagonists
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HEART FAILURE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-06-08
DOI
10.1002/ejhf.1217
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Associations of serum potassium levels with mortality in chronic heart failure patients
- (2017) Mette Aldahl et al. EUROPEAN HEART JOURNAL
- Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality
- (2017) Julio Núñez et al. CIRCULATION
- Serum Potassium Levels and Outcome in Patients With Chronic Heart Failure
- (2016) Sarah Hoss et al. AMERICAN JOURNAL OF CARDIOLOGY
- Efficacy and safety of mineralocorticoid receptor antagonists for patients with heart failure and diabetes mellitus: a systematic review and meta-analysis
- (2016) Meng-Die Chen et al. BMC Cardiovascular Disorders
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN JOURNAL OF HEART FAILURE
- Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro–B-type natriuretic peptide levels: An individual patient data analysis
- (2015) Khibar Salah et al. AMERICAN HEART JOURNAL
- Changes in Serum Potassium Levels During Hospitalization in Patients With Worsening Heart Failure and Reduced Ejection Fraction (from the EVEREST Trial)
- (2015) Sadiya S. Khan et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors
- (2015) Bertram Pitt et al. EUROPEAN JOURNAL OF HEART FAILURE
- Incidence, Predictors, and Outcomes Related to Hypo- and Hyperkalemia in Patients With Severe Heart Failure Treated With a Mineralocorticoid Receptor Antagonist
- (2014) Orly Vardeny et al. Circulation-Heart Failure
- Spironolactone for Heart Failure with Preserved Ejection Fraction
- (2014) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy
- (2013) Patrick Rossignol et al. Circulation-Heart Failure
- 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2013) Clyde W. Yancy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Serum Potassium Levels and Mortality in Acute Myocardial Infarction
- (2012) Abhinav Goyal et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Update on Aldosterone Antagonists Use in Heart Failure With Reduced Left Ventricular Ejection Fraction Heart Failure Society of America Guidelines Committee
- (2012) Javed Butler et al. JOURNAL OF CARDIAC FAILURE
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
- (2010) Faiez Zannad et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started